Market Overview

Edwards Lifesciences Shares Fall As FDA Reports Recall Of Sapien 3 Ultra


The Food and Drug Administration reported Edwards Lifesciences (NYSE: EW) has recalled Sapien 3 Ultra delivery system due to burst balloons during surgery.

Reports first emerged in June that the company had issued a field safety notice regarding its Sapien 3 Ultra system for transcatheter aortic valve replacement (TAVR), warning physicians it has received reports of burst balloons.

This burst balloons may result in vascular injury, bleeding, or surgical intervention.

Edwards Lifesciences shares were trading down 3% to $215 at time of publication. The stock has a 52-week high of $226.41 and a 52-week low of $136.44.

Related Links:

The Daily Biotech Pulse: ViiV's Long-Acting HIV Drug Meets Study Goal, Retrophin Flunks Late-Stage Study

Clearside Stock Plummets After Company Hints At Complete Response Letter For Macular Edema Drug

Posted-In: News FDA


Related Articles (EW)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

UK To Import Columbia Care CBD Tablets For Clinical Study

Freight Tonnage Will Grow 25.6 Percent By 2030, ATA Projects